Navigation Links
Vioxx Settlement Announced
Date:11/9/2007

TAMPA, Fla., Nov. 9 /PRNewswire/ -- After several years of litigation, Merck has agreed to pay $4.85 billion in a settlement over Vioxx. The medication was pulled off the market in 2004 after a clinical trial proved it increased the risks of heart attacks and strokes. It is one of the largest pharmaceutical settlements in history.

James Hoyer Newcomer and Smiljanich is pleased this long process is coming to a resolution. The firm has more than a dozen clients who've suffered the ill-effects of taking Vioxx. "This settlement was a long time coming, but one that will finally give our clients some relief from the harm they suffered," said Attorney John Newcomer.

Nearly 30-thousand lawsuits have been filed nationwide against Merck because of Vioxx. Plaintiffs will receive different settlement payments depending on the severity of their injuries and the length of time they took Vioxx. Plaintiff Alvin Jupiter, of Tampa, suffered a heart attack in 2001 after taking Vioxx. He said, "I'm glad to see something coming to fruition on this. So many people were hurt."

James Hoyer Newcomer & Smiljanich will review details of the settlement over the coming weeks and work to ensure our clients are compensated fairly.


'/>"/>
SOURCE James Hoyer Newcomer & Smiljanich
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. New study may explain Vioxx side-effects
2. Study Points to Cause of Vioxx Heart Risk
3. Vioxx Ban Tied to Rise in Serious GI Trouble
4. The Lanier Law Firm Announces $4.85 Billion National Vioxx Settlement With Merck & Co. Inc.
5. Vioxx Settlement Puts Painkillers Back in the Spotlight
6. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
7. MaxLife Fund Corp. purchases a portfolio of Life Settlement Policies with a face value of $4,000,000
8. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
9. $52.5 Million Settlement Against Sepracor Inc. Approved
10. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
11. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , ... June 26, 2016 , ... On June 10-11, ... of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, ... the city’s history as home to some of the world’s leading providers of cereal ...
(Date:6/26/2016)... ... ... Kasmer, a legally blind and certified personal trainer is helping to develop a weight loss ... plans to fix the two major problems leading the fitness industry today:, ... , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 26, 2016 One of Australia,s ... the formation of a new biotechnology company, Noxopharm Limited [ABN 50 ... an IPO and to list on the ASX. Noxopharm ... ready to enter a Phase 1 clinical study later this year. ... address one of the biggest problems facing cancer patients - the ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: